As a CRO specialising in clinical trials for rare and orphan diseases, Rare Disease Day has become a special cause ...Read more >
Rare Disease Day offers a valuable opportunity to raise awareness of rare disease and campaign for health equity. We are ...Read more >
Vault CTMS and Vault eTMF provide complete visibility into trials, enabling CRO to deliver value-added services to sponsors PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva ...Read more >
Providing oncology drug developers with the successful delivery of early phase oncology studies Slough, Berkshire, United Kingdom: Simbec-Orion announced a ...Read more >
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. ...Read more >
Simbec-Orion COVID-19 Update 1 April 2020
Dr Fabrice Chartier explains the complex nature of developing treatments for rare diseases. Read the article on page 17.
Celebrating success across life sciences London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised ...Read more >
If you think we could be right for you, get in touch.